Lexicon Pharmaceuticals
LXRX
#6754
Rank
NZ$1.39 B
Marketcap
NZ$3.14
Share price
0.57%
Change (1 day)
19.82%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -NZ$0.11 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are NZ$41.46 Million. In 2025 the company made an earning of -NZ$89.86 Million, an increase over its 2024 earnings that were of -NZ$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.11 Billion18.69%
2025 -NZ$89.86 Million-74.88%
2024 -NZ$0.36 Billion13.15%
2023 -NZ$0.32 Billion73.74%
2022 -NZ$0.19 Billion16.16%
2021 -NZ$0.16 Billion49.82%
2020 -NZ$0.11 Billion-147.19%
2019 NZ$0.22 B-203.42%
2018 -NZ$0.22 Billion-15.31%
2017 -NZ$0.26 Billion0.2%
2016 -NZ$0.26 Billion2920.7%
2015 -NZ$8.36 Million-95.33%
2014 -NZ$0.18 Billion-3.61%
2013 -NZ$0.19 Billion-5.52%
2012 -NZ$0.2 Billion-4.17%
2011 -NZ$0.21 Billion15.5%
2010 -NZ$0.18 Billion8.36%
2009 -NZ$0.17 Billion-4.81%
2008 -NZ$0.18 Billion28.79%
2007 -NZ$0.14 Billion35.71%
2006 -NZ$98.58 Million52.91%
2005 -NZ$64.47 Million-23.89%
2004 -NZ$84.7 Million-24.19%
2003 -NZ$0.12 Billion-0.48%
2002 -NZ$0.12 Billion44.12%
2001 -NZ$77.89 Million23.01%
2000 -NZ$63.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
NZ$13.63 B-12,595.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$2.07 B-1,998.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$9.22 B-8,552.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-NZ$0.91 Billion 727.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.43 B-499.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.14 B-229.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-NZ$41.49 Million-61.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.26 B-343.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$29.49 Million-72.97%๐Ÿ‡บ๐Ÿ‡ธ USA